Evidence map›Paper›PMID 39026248›Full record

ReviewNutrition & metabolism2024

Mechanisms of regulation of glycolipid metabolism by natural compounds in plants: effects on short-chain fatty acids.

Jiarui Li, Jinyue Zhao, Chuanxi Tian, Lishuo Dong, Zezheng Kang, Jingshuo Wang, Shuang Zhao, Min Li, Xiaolin Tong

Abstract readReview
In one paragraph

Review in Nutrition & metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Trial
  2. Review
  3. Molecules (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Correlative study ofFrontiers in microbiology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiarui Li *College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Jinyue Zhao *College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Chuanxi Tian *Beijing University of Chinese Medicine, Beijing, China.
Lishuo DongCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Zezheng KangCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Jingshuo WangThe Affiliated Hospital, Changchun University of Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Shuang ZhaoCollege of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
Min LiResearch Laboratory of Molecular Biology, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, China. limin-72114@163.com.
Xiaolin TongGuang'anmen Hospital, Academician of Chinese Academy of Sciences, China Academy of Traditional Chinese Medical Sciences, Beijing, China. tongxiaolin@vip.163.com.

Funding

Clinical Research Center Construction Project of Guang'anmen Hospital 2022LYJSZX01~2022LYJSZX29High Level Chinese Medical Hospital Promotion Project HLCMHPP2023084
6 · The paper itself

Abstract

backgroundNatural compounds can positively impact health, and various studies suggest that they regulate glucose‒lipid metabolism by influencing short-chain fatty acids (SCFAs). This metabolism is key to maintaining energy balance and normal physiological functions in the body. This review explores how SCFAs regulate glucose and lipid metabolism and the natural compounds that can modulate these processes through SCFAs. This provides a healthier approach to treating glucose and lipid metabolism disorders in the future.

methodsThis article reviews relevant literature on SCFAs and glycolipid metabolism from PubMed and the Web of Science Core Collection (WoSCC). It also highlights a range of natural compounds, including polysaccharides, anthocyanins, quercetins, resveratrols, carotenoids, and betaines, that can regulate glycolipid metabolism through modulation of the SCFA pathway.

resultsNatural compounds enrich SCFA-producing bacteria, inhibit harmful bacteria, and regulate operational taxonomic unit (OTU) abundance and the intestinal transport rate in the gut microbiota to affect SCFA content in the intestine. However, most studies have been conducted in animals, lack clinical trials, and involve fewer natural compounds that target SCFAs. More research is needed to support the conclusions and to develop healthier interventions.

conclusionsSCFAs are crucial for human health and are produced mainly by the gut microbiota via dietary fiber fermentation. Eating foods rich in natural compounds, including fruits, vegetables, tea, and coarse fiber foods, can hinder harmful intestinal bacterial growth and promote beneficial bacterial proliferation, thus increasing SCFA levels and regulating glucose and lipid metabolism. By investigating how these compounds impact glycolipid metabolism via the SCFA pathway, novel insights and directions for treating glucolipid metabolism disorders can be provided.

Indexed as

Glucose metabolismLipid metabolismNatural compoundsShort-chain fatty acids

Identifiers

PMID39026248
PMCPMC11256480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.